about
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (N...
Read More
13.74
-1.44
(-9.49%)
31,308
XNAS Volume
XNAS 09 Oct, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Eloxx Pharma is on 13 Oct 2026 for the purpose of Eloxx Pharmaceuticals Inc Annual General Meeting for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Eloxx Pharma Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..